– UK, Manchester – PZ Cussons plc (LON: PZC) today announced the appointment of Vivek Ahuja to its Board as a Non-Executive Director effective from 1 May 2024.
“On behalf of the Board, I am delighted to announce Vivek’s appointment. He has a wealth of invaluable international experience in senior general management and senior financial roles, and I am sure that he will make a significant contribution to the Board and the business over the years ahead.” said Board Chair, David Tyler.
Vivek Ahuja will also join the Audit & Risk Committee as Chair and the Nomination Committee as a member.
About Vivek Ahuja
Vivek Ahuja has over 30 years of experience in global finance and is currently a Non-Executive Director and Chair of the Risk Committee of NatWest Markets plc. He is also an independent Member of the Council of King’s College London. He was most recently CEO of Terra Firma Capital Partners Ltd, a leading European Private Equity Firm, and before that Deputy Group CFO at Standard Chartered plc.
About PZ Cussons
PZ Cussons is a FTSE250 listed consumer goods business, headquartered in Manchester, UK. We employ nearly 3,000 people across Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have created products to delight, care for, and nourish consumers. Across our core categories of Hygiene, Baby, and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa, and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy, and captured by our purpose: For everyone, for life, for good.
SOURCE: https://www.pzcussons.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.